Tamarack Advisers’s Teladoc Health TDOC Stock Holding History

Tamarack Advisers’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-305,000	Closed	-$7.63M	–	37
2017 Q1	$7.63M	Sell	305,000 -110,600	-27%	-$2.3M	4.76%	8
2016 Q4	$6.86M	Buy	415,600 +90,600	+28%	+$1.54M	4.85%	10
2016 Q3	$5.82M	Buy	+325,000	New	+$5.7M	1.83%	20

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Tamarack Advisers's TDOC Position: Q2 2017 in Review

Tamarack Advisers sold out of Teladoc Health (TDOC) in Q2 2017, closing a stake of 305,000 shares — an estimated $7.63M sold.

Tamarack Advisers first reported a position in TDOC in Q3 2016 and held it in 3 quarters. The position peaked at $7.63M in Q1 2017. 165 funds tracked by Wall St. Rank hold TDOC as of Q2 2017.

Tamarack Advisers reported no remaining Teladoc Health position as of Q2 2017 after selling out during the quarter.
Tamarack Advisers sold 305,000 Teladoc Health shares in Q2 2017, an estimated $7.63M.
Tamarack Advisers first reported a position in Teladoc Health in Q3 2016 and held it in 3 quarters.
Tamarack Advisers's Teladoc Health position peaked at $7.63M in Q1 2017.
165 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2017.

Based on Tamarack Advisers's 13F filing for Q2 2017, filed 8 Aug 2017.